₹368.25
▼ -5.99 -1.60%
17 Jul 2026
NSE Listed
Indraprastha Medical Corp (INDRAMEDCO)
Volume: 80,105Avg Vol 1W: 85,817.6Avg Vol 1M: 1,10,595.852W Range:₹342₹640.85
Key Ratios
Checked 3h agoMarket Cap₹3,431 Cr
Current Price₹368.25
Previous Close₹374.24
High / Low (52w)₹640.85 / ₹342
Volume80,105
Avg Vol (1W)85,817.6
Avg Vol (1M)1,10,595.8
Stock P/E82.25
Book Value₹80.76
Dividend Yield107%
ROE24.8%
ROA18.52%
Revenue (TTM)₹1,379 Cr
Revenue Growth—
Profit Margin12.39%
Total Debt—
Shares Outstanding9 Cr
Face Value₹10
EPS (TTM)₹20.03
P/B4.63
Debt / Equity0.06
50 DMA₹381.07
200 DMA₹433.36
Day change-1.60%
Price Chart
₹368.25▼ 24.03% · 1Y
2025-07-172026-07-16
20-day avg volume: 1.1L shares
Pros
- Healthy return on equity of 24.8%.
- Pays a dividend yield of 107.0%.
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 82.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹348 Cr | ₹350 Cr | ₹325 Cr | ₹334 Cr | ₹365 Cr | ₹381 Cr | ₹372 Cr | ₹365 Cr |
| EBITDA | ₹61 Cr | ₹59 Cr | ₹46 Cr | ₹57 Cr | ₹70 Cr | ₹68 Cr | ₹58 Cr | ₹57 Cr |
| Net Profit | ₹45 Cr | ₹42 Cr | ₹33 Cr | ₹41 Cr | ₹51 Cr | ₹49 Cr | ₹41 Cr | ₹42 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹753 Cr | ₹789 Cr | ₹831 Cr | ₹614 Cr | ₹891 Cr | ₹1,109 Cr | ₹1,262 Cr | ₹1,379 Cr |
| EBITDA | ₹43 Cr | ₹51 Cr | ₹54 Cr | ₹8 Cr | ₹82 Cr | ₹121 Cr | ₹170 Cr | ₹223 Cr |
| Net Profit | ₹21 Cr | ₹28 Cr | ₹44 Cr | ₹2 Cr | ₹59 Cr | ₹86 Cr | ₹124 Cr | ₹161 Cr |
| EPS | 2.3 | 3.1 | 4.76 | 0.25 | 6.39 | 9.4 | 13.52 | 17.56 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹432 Cr | ₹422 Cr | ₹449 Cr | ₹432 Cr | ₹462 Cr | ₹555 Cr | ₹723 Cr | ₹852 Cr |
| Total Liabilities | ₹200 Cr | ₹178 Cr | ₹181 Cr | ₹159 Cr | ₹136 Cr | ₹176 Cr | ₹245 Cr | ₹255 Cr |
| Equity | ₹232 Cr | ₹244 Cr | ₹268 Cr | ₹273 Cr | ₹325 Cr | ₹379 Cr | ₹478 Cr | ₹597 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹36 Cr | ₹114 Cr | ₹154 Cr | ₹247 Cr | ₹218 Cr |
| Investing | ₹-19 Cr | ₹-74 Cr | ₹-108 Cr | ₹-158 Cr | ₹-111 Cr |
| Financing | ₹-3 Cr | ₹-3 Cr | ₹-26 Cr | ₹-32 Cr | ₹-46 Cr |
| Free Cash Flow | ₹36 Cr | ₹114 Cr | ₹154 Cr | ₹247 Cr | ₹218 Cr |
Shareholding
Promoter 51% Institutions 3.31% Public 45.69%
Efficiency & Working Capital
ROCE32.4%
Interest Coverage35.5
Dividend Payout—
Debtor Days20 d
Inventory Days2 d
Payable Days33 d
Cash Conversion Cycle-11 d
Working Capital Days22 d
Shareholding Details
As of 2026-06-30
Promoter51%
FII2.8%
DII0.6%
Institutions3.4%
Public45.6%
Promoter Pledge0%
No. of Shareholders75,098
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% |
| FIIs | 0.8% | 0.9% | 1.1% | 1.7% | 2.6% | 2.9% | 2.9% | 2.7% | 2.4% | 2.7% | 2.4% | 2.8% |
| DIIs | 6.7% | 6.4% | 4.9% | 3.2% | 3.2% | 3.2% | 3.6% | 3.6% | 3.5% | 0.8% | 0.9% | 0.6% |
| Public | 41.5% | 41.7% | 43% | 44.2% | 43.2% | 42.9% | 42.5% | 42.7% | 43.1% | 45.4% | 45.7% | 45.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 47,865 | 51,448 | 54,158 | 55,103 | 64,671 | 69,697 | 70,491 | 70,211 | 70,914 | 71,225 | 72,980 | 75,098 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| President Of India | Shareholding of Promoter and Promoter Group | 26% | 2.38 Cr |
| Apollo Hospitals Enterprise Limited | Shareholding of Promoter and Promoter Group | 22% | 2.02 Cr |
| Vanjana Sundar Iyer | Public Shareholding | 2% | 18,40,681 |
| Emedlife Insurance Broking Services Limited | Public Shareholding | 1.7% | 15,50,701 |
| Wedgewood Holdings Limited | Shareholding of Promoter and Promoter Group | 1.6% | 14,75,000 |
| Citadel Research And Solutions Limited | Public Shareholding | 1.3% | 11,74,983 |
| Pcr Investments Limited | Shareholding of Promoter and Promoter Group | 0.4% | 3,87,423 |
| Prathap C Reddy | Shareholding of Promoter and Promoter Group | 0.3% | 2,37,187 |
| Preetha Reddy | Shareholding of Promoter and Promoter Group | 0.2% | 2,02,650 |
| Sucharitha P Reddy | Shareholding of Promoter and Promoter Group | 0.2% | 1,60,689 |
| Suneeta Reddy | Shareholding of Promoter and Promoter Group | 0.2% | 1,38,293 |
| Shobana Kamineni | Shareholding of Promoter and Promoter Group | 0.1% | 1,16,918 |
| Sangita Reddy | Shareholding of Promoter and Promoter Group | 0% | 9,900 |
| K S Baidwan | Shareholding of Promoter and Promoter Group | 0% | 1 |
| P V Jayakrishnan | Shareholding of Promoter and Promoter Group | 0% | 1 |
| Ramesh Chander | Shareholding of Promoter and Promoter Group | 0% | 1 |
| Vineeta Rai | Shareholding of Promoter and Promoter Group | 0% | 1 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Pratap C Reddy | 0 | 0% | 2026-06-30 |
| Preetha Reddy | 0 | 0% | 2026-06-30 |
| Sucharitha P Reddy | 0 | 0% | 2026-06-30 |
| Suneeta Reddy | 0 | 0% | 2026-06-30 |
| Shobana Kamineni | 0 | 0% | 2026-06-30 |
| Sangita Reddy | 0 | 0% | 2026-06-30 |
| K S Baidwan | 0 | 0% | 2026-06-30 |
| P V Jayakrishan | 0 | 0% | 2026-06-30 |
| Ramesh Chander | 0 | 0% | 2026-06-30 |
| Vineetarai | 0 | 0% | 2026-06-30 |
| President Of India | 0 | 0% | 2026-06-30 |
| Apollo Hospitals Enterprises Limited | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Prathap C Reddy | Vice Chairman | 2025 |
| Suneeta Reddy | Non-Exec & Non-Independent Dir | 2025 |
| Sangita Reddy | Non-Exec & Non-Independent Dir | 2025 |
| Mahesh Verma | Non Independent Non Executive Director / Nominee | 2025 |
| MADHUMITA GANGULI | Independent Non Exe. Director | 2025 |
| Salil Singhal | Independent Non Exe. Director | 2025 |
| Vineeta Rai | Independent Non Exe. Director | 2025 |
| Vinayak Chatterjee | Independent Non Exe. Director | 2025 |
| P Shivakumar | ED / MD / Promoter | 2025 |
| Sandip Somany | Independent Non Exe. Director | 2025 |
| Tejpreet S Chopra | Independent Non Exe. Director | 2025 |
| SUDHIR JALAN | Independent Non Exe. Director | 2025 |
| PRIYA RANJAN | AVP - Corporate Affairs & Legal / CS | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Healthcare | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 100 | 92 | 92 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-09-18 | ₹4.5 (45%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 8 | 149 | 157 |
| 2025 | 0 | 0 | 0 | 0 | 12 | 12 |
| 2025 | 0 | 0 | 0 | 0 | 17 | 17 |
Substantial Acquisitions (SAST)
1 disclosure(s)
Market29/02/2024 - 04/04/2024 · 27,81,897
Company Information
🌐 www.delhi.apollohospitals.com ↗
📍 Sarita Vihar, Delhi-Mathura Road, New Delhi, New Delhi, 110076
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search